Please provide your email address to receive an email when new articles are posted on . Both 0.03% and 0.05% atropine eyedrops significantly enlarged pupil size. Low-dose atropine drops had no ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The 2-year incidence of myopia was 28.4% in the 0.05% ...

A Prescription Drug User Fee Act target date of October 23, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...

Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years, ...

Prior to this research, recent trials conducted primarily in East Asia showed a benefit from .01 percent atropine in slowing myopia. The randomized controlled trial, conducted by the Pediatric Eye ...

Atropine eye drops given once a day to treat amblyopia, or lazy eye, the most common cause of visual impairment in children, work as well as the standard treatment of patching one eye. This research ...

According to a secondary analysis of the 24- Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, 0.05% atropine eye drops were more effective in controlling myopia progression and axial ...

In a cohort of over 1.2 million Taiwanese children followed up for at least 5 years, those with myopia had a higher risk for ocular problems than those without the condition. However, among children ...

A study conducted at Vanderbilt University Medical Center and 11 other hospitals and practices across the United States shows that use of low-dose atropine eyedrops, commonly used in a higher dose to ...

A new clinical trial has found that a common eye drop is a safe and effective way to slow the progression of nearsightedness in children. The finding may provide an easier way of treating the ...

LONG BEACH, Calif. -- Low-dose atropine drops showed potential as a noninvasive alternative for managing vitreous floaters, a small retrospective study suggested. A majority of patients who completed ...